Very quiet week in the psychedelic market with very little news, but some companies still got attention
Revive Therapeutics | RVV
The most talked about company this week is Revive Therapeutic | RVV. After hitting a high of 0.39 last week and falling back considerably the following days, Revive climbed 88% to end the week at 0.30.
More and more investors are following the company, which is awaiting acceptance by the FDA of phase 3 confirmatory study to evaluate Bucillamine in the treatment of patients with mild-moderate COVID-19.
This answer is likely to be a game changer for this small penny stock with a value around 50 Million.
Visit Revive Therapeutics profile | HERE
M2Bio Sciences, Inc | WUHN
Following the news that M2Bio Sciences | WUHN has signed a letter of intention to pursue a Partnership where Jugular will support and offer its expertise to the Company in creating a specialized division within MJ Medtech that focuses on marketable innovation within the functional foods sector, the CEOs of 2 companies gave an interesting interview which leads us to believe in a possible alliance or merger between the 2 companies ?
Psychedelics market cap
Visit M2Bio Sciences profile | HERE
Champignon Brands Inc | SHRM
Quiet week for Mindmed and Numinus which fell slightly with little significant news
Mindmed | MMED
Numinus | NUMI
M2Bio Sciences inc, an opportunity of a lifetime?| LOOK HERE
For more information on the psychedelics market and all the companies involved | HERE
Sign up for MORE news updates !
This article is written and published by The Cannabis Stock
Disclaimer : The Cannabis Stock wants to promote the cannabis market with the best articles and news on the market. The Cannabis Stock does not recommend selling or buying any of the company mentioned and is not responsible for any losses that may result. The Cannabis Stock are engaged in the business of marketing and advertising companies
The Cannabis Stock and its employees may from time to time own shares of the companies named in the articles. All the facts reported by the cannabis stock are information that comes directly from the companies, from their website or on Sedar and are only published as information.
Disclosure : Wuhan General group inc and Revive Therapeutics are clients of The Cannabis Stock.